ID: h-65b79f09
Hypothesis
ApoE4-Mediated Failure of Cholesterol Efflux as Memory Maintenance Mechanism
Incomplete hypothesis (truncated).
🧬 APOE (ApoE4 isoform) → cholesterol metabolism🩺 neuroinflammation🎯 Composite 52%💱 $0.55▼7.6%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 7 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Incomplete hypothesis (truncated). ApoE4 isoform from astrocytes fails to mediate proper cholesterol efflux from microglia, maintaining pathological trained immunity states. Loss of ApoE4 function leads to cholesterol accumulation in microglial lipid rafts, stabilizing NF-κB complexes and perpetuating inflammatory memory.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["APOE4 Isoform<br/>Structural Instability"]
B["Impaired Lipid Loading<br/>Reduced Cholesterol Efflux"]
C["LRP1 Reduced Binding<br/>BBB Clearance Deficit"]
D["Amyloid-beta<br/>Accumulation"]
E["Synaptic Dysfunction<br/>Membrane Disruption"]
F["Neurodegeneration<br/>Cognitive Decline"]
G["APOE3 Comparison<br/>Normal Lipidation"]
A --> B
B --> C
C --> D
D --> E
E --> F
G -.->|"protective"| C
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix7 supports2 contradicts
Supports
Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation.
Supports
Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.
Supports
A "multi-omics" analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice.
Supports
Apolipoprotein-E allele-specific regulation of nitric oxide production.
Supports
Apolipoprotein E isoforms and their Cys-thiol modifications impact LRP1-mediated metabolism of triglyceride-rich lipoproteins.
Contradicts
ApoE4 primarily studied in amyloid pathology; direct trained immunity effects unclear
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — APOE
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for APOE (ApoE4 isoform) → cholesterol metabolism from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for APOE (ApoE4 isoform) → cholesterol metabolism.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.7%
Volatility
Medium
0.0462
Events (7d)
3
Price History
▼7.6%💾 Resource Usage
LLM Tokens
13,698
$0.0411
Total Cost
$0.0411
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF APOE4 homozygous AD patients (APOE4/4) are stratified and compared with APOE3/3 patients, THEN post-mortem prefrontal cortex microglia will show ≥2-fold higher cholesterol content in lipid raft fra | Elevated microglial lipid raft cholesterol and increased NF-κB activation in APOE4 carriers, correlating with cognitive impairment | — no observation — | pending | 0.55 |
| IF APOE4 knock-in mice are treated with an LXR agonist (to pharmacologically restore cholesterol efflux), THEN microglial lipid raft cholesterol levels will decrease by ≥40% and serum IL-6 responses t | Reduced microglial cholesterol accumulation and attenuated inflammatory memory response (decreased IL-6, TNF-α) upon secondary immune challenge | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF APOE4 knock-in mice are treated with an LXR agonist (to pharmacologically restore cholesterol efflux), THEN microglial lipid raft cholesterol levels will decrease by ≥40% and serum IL-6 responses to peripheral LPS challenge will be reduced by ≥50% compared to vehicle-treated APOE4 mice within 14
Predicted outcome: Reduced microglial cholesterol accumulation and attenuated inflammatory memory response (decreased IL-6, TNF-α) upon secondary immune challenge
Falsification: No significant reduction in microglial cholesterol or inflammatory cytokines despite LXR agonist treatment; would indicate cholesterol efflux failure is not the limiting factor
pendingconf 55%
IF APOE4 homozygous AD patients (APOE4/4) are stratified and compared with APOE3/3 patients, THEN post-mortem prefrontal cortex microglia will show ≥2-fold higher cholesterol content in lipid raft fractions and ≥1.8-fold higher NF-κB p65 nuclear localization compared to APOE3 carriers, with these me
Predicted outcome: Elevated microglial lipid raft cholesterol and increased NF-κB activation in APOE4 carriers, correlating with cognitive impairment
Falsification: No difference in microglial cholesterol or NF-κB activation between APOE genotypes; would indicate ApoE4 does not regulate microglial cholesterol storage in humans
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.